|Bid||91.09 x 100|
|Ask||91.15 x 200|
|Day's Range||89.29 - 91.44|
|52 Week Range||71.90 - 106.27|
|PE Ratio (TTM)||20.59|
|Earnings Date||May 2, 2018 - May 7, 2018|
|Forward Dividend & Yield||1.52 (1.70%)|
|1y Target Est||106.00|
AmerisourceBergen Corporation today announced that it will present at the Barclays Global Healthcare Conference at 2:05 p.m. ET on Tuesday, March 13, 2018.
The pharmacy benefits business, which tries to negotiate down the price of prescription medicines for large employers, has drawn fire from the Trump administration and Congress, who have questioned whether those discounts are really being passed on to consumers. Cigna's deal follows close on the heels of a rival $69-billion merger between CVS Health Corp (CVS.N) and health insurer Aetna Inc (AET.N), announced in December.
Kentucky's attorney general on Thursday sued AmerisourceBergen Corp, accusing the drug distributor of contributing to opioid abuse in the state by filling suspiciously large or frequent pharmacy orders of prescription painkillers. The lawsuit by Kentucky Attorney General Andy Beshear was his fourth to date seeking to hold a corporation responsible for its role in the national opioid epidemic.
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
From yesterday's research, analysts parsed 133 10-K filings and collected 20,292 data points. In total, they made 3,309 forensic accounting adjustments with a dollar value of $434 billion. Analyst Lindsay Bohannon found an unusual item yesterday in Diplomat Pharmacy’s (DPLO) 10-K.
Depomed (DEPO) has adopted a three-pronged business strategy with three key elements: maintain, build, and grow. Depomed aims to maintain its Nucynta franchise of pain products through the commercialization agreement it entered into with Collegium Pharmaceutical in December 2017. Under this agreement, Depomed granted commercialization rights for the Nucynta franchise of pain products to Collegium Pharmaceutical in the US.
U.S. Food and Drug Administrator Scott Gottlieb on Wednesday criticized drugmakers, pharmacy benefit managers and health insurers for "Kabuki drug-pricing constructs" that he said expose consumers to high out-of-pocket costs and discourage competition. Gottlieb delivered the remarks at an annual conference of health insurers in a speech largely aimed at promoting biosimilars, rival treatments that are as effective as the original but cheaper. Kabuki is a form of Japanese theater known for its dramatization and elaborate make-up of its performers.
AmerisourceBergen (ABC) is one of the largest global pharmaceutical sourcing and distribution services companies. AmerisourceBergen delivers innovative programs and services designed to increase the effectiveness of the pharmaceutical supply chain in human and animal health. The company operates through two business segments—pharmaceutical distribution services and the other segment.
Stock Monitor: Cardinal Health Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 01, 2018 / Active-Investors.com has just released a free earnings report on AmerisourceBergen Corp. (NYSE: ABC ). ...
According to a recent report by CNBC, talks between Walgreens Boots Alliance (WBA) and AmerisourceBergen Corp. (ABC) ended without an agreement. The two companies were reportedly discussing a potential partnership where Walgreens would acquire the remaining stake of AmerisourceBergen, which it doesn’t already own. Walgreens owns a 26.0% stake in the company. Walgreens and ABC stock fell after the report on February 27, 2018.
The federal government, backing litigation by states and cities, will seek reimbursement from major drug companies and distributors to recover costs it has borne from the opioid epidemic, the U.S. Justice Department said on Tuesday. Attorney General Jeff Sessions said Washington would side with plaintiffs in the litigation that accuses the drug makers of deceptively marketing opioids and alleges that distributors ignored red flags indicating the painkillers were being diverted for improper uses.
WASHINGTON (AP) — The Justice Department said Tuesday it will support local officials in hundreds of lawsuits against manufacturers and distributors of powerful opioid painkillers that are fueling the nation's drug abuse crisis.
AmerisourceBergen's stock price dropped by more than 3 percent Tuesday afternoon after multiple reports said talks on the possible takeover of the Valley Forge wholesale pharmaceutical distributor by the retail pharmacy chain operator Walgreens Boots Alliance had collapsed. A spokeswoman for AmerisourceBergen said in response to the initial takeover talk rumors that the company does not comment on market speculation.
AmerisourceBergen stock plunged amid reports the firm's talks over a potential takeover by Walgreens Boots Alliance have collapsed.